Retraction
Tim-3 expression in cervical cancer promotes tumor metastasis
Paper Information
Record ID:
64880
Author(s):
Publication Date:
January 15, 2013
Retraction Date:
July 25, 2024
(1.3 year years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0308113Citations (141)
141
Total Citations5
Post-Retraction(3.5%)
135
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
5
Within 1 year
0
After 2+ years
251
Days since retraction (latest)
Targeting immune checkpoints in gynecologic cancer: updates & perspectives for pathologists
Anne M. Mills, Tim N. Bullock, Kari L. Ring
Modern Pathology
Open Access
Published: Sep 2021
12 citations
12 citations
1052 days before retraction
The Emerging Role of T-Cell Immunoglobulin Mucin-3 in Breast Cancer: A Promising Target For Immunotherapy
Yizi Cong, Jing Liu, Gang Chen et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Aug 2021
9 citations
9 citations
1066 days before retraction
Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia
Jun Wang, Lu Yang, Feng‐Ting Dao et al. (11 authors)
Leukemia & lymphoma/Leukemia and lymphoma
Published: Aug 2021
6 citations
6 citations
1072 days before retraction
Clinical Significance of Expression of Immunoadjuvant Molecules (LAG-3, TIM-3, OX-40) in Neoadjuvant Chemotherapy for Breast Cancer
Yuka Asano, Shinichiro Kashiwagi, Sae Ishihara et al. (10 authors)
Research Square (Research Square)
Open Access
Published: Aug 2021
1077 days before retraction
Structure and Functions of T-cell Immunoglobulin-domain and Mucin- domain Protein 3 in Cancer
Xinjie Lu
Current Medicinal Chemistry
Published: Aug 2021
7 citations
7 citations
1081 days before retraction
TIM-3: An update on immunotherapy
Li‐Zhen Zhao, Shaoyun Cheng, Lin Fan et al. (5 authors)
International Immunopharmacology
Published: Jul 2021
151 citations
151 citations
1119 days before retraction
TIM‐3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways
Yoshikane Kikushige
Cancer Science
Open Access
Published: Jun 2021
27 citations
27 citations
1128 days before retraction
Role of Tim-3 in regulating tumorigenesis, inflammation, and antitumor immunity therapy
Yuting Cao, Qiang Li, Huihui Liu et al. (6 authors)
Cancer Biomarkers
Published: Jun 2021
4 citations
4 citations
1147 days before retraction
Cervical Cancer Immunotherapy: Facts and Hopes
Louise Ferrall, Ken Y. Lin, Richard B.S. Roden et al. (5 authors)
Clinical Cancer Research
Open Access
Published: Apr 2021
284 citations
284 citations
1190 days before retraction
Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity
Ranferi Ocaña‐Guzmán, Norma A. Téllez-Navarrete, Lucero A. Ramón‐Luing et al. (10 authors)
Journal of Immunology Research
Open Access
Published: Apr 2021
16 citations
16 citations
1191 days before retraction
Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC
Reihaneh Alsadat Mahmoudian, Sahar Mozhgani, Mohammad Reza Abbaszadegan et al. (6 authors)
Journal of Molecular Histology
Published: Apr 2021
24 citations
24 citations
1191 days before retraction
Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells
Maria Davern, Noel E. Donlon, Andrew Sheppard et al. (13 authors)
Translational Oncology
Open Access
Published: Mar 2021
17 citations
17 citations
1220 days before retraction
<i><scp>TIM</scp>‐3</i> polymorphism is involved in the progression of esophageal squamous cell carcinoma by regulating gene expression
Saijin Cui, Yan Li, Rong‐Miao Zhou et al. (8 authors)
Environmental and Molecular Mutagenesis
Published: Mar 2021
3 citations
3 citations
1227 days before retraction
TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation
Kui Zang, Liangliang Hui, Min Wang et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Feb 2021
46 citations
46 citations
1249 days before retraction
The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists
Tjalling Bosse, Sigurd Lax, Nadeem R. Abu‐Rustum et al. (4 authors)
International Journal of Gynecological Pathology
Open Access
Published: Feb 2021
13 citations
13 citations
1262 days before retraction
Checkpoint proteins in patients with precancer and cervical cancer
Е. V. Kayukova, Л. Ф. Шолохов, Tatiana Belokrinitskaya et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2021
2 citations
2 citations
1262 days before retraction
The role of Tim‐3/Galectin‐9 pathway in T‐cell function and prognosis of patients with human papilloma virus‐associated cervical carcinoma
Zhifang Chen, Di Dong, Yuejie Zhu et al. (5 authors)
The FASEB Journal
Open Access
Published: Feb 2021
26 citations
26 citations
1262 days before retraction
Laboratory biomarkers of an effective antitumor immune response. Clinical significance.
Анна Малкова, Vladimir V. Sharoyko, Natalia V. Zhukova et al. (5 authors)
Cancer Treatment and Research Communications
Open Access
Published: Jan 2021
2 citations
2 citations
1301 days before retraction
Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis
Fabiola Solorzano‐Ibarra, Alan Guillermo Alejandre‐Gonzalez, Pablo Cesar Ortiz‐Lazareno et al. (12 authors)
Clinical & Experimental Immunology
Open Access
Published: Dec 2020
17 citations
17 citations
1322 days before retraction
Elevated Expression of T-Cell Immunoglobulin and Mucin Domain 3 on T Cells from Peripheral Blood in Patients with Cervical Carcinoma
Juan Li, Xiaofei Sun, Ying Shen et al. (5 authors)
Gynecologic and Obstetric Investigation
Published: Dec 2020
1 citation
1 citation
1329 days before retraction
Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities
Minhong Shen, Yibin Kang
Genes & Development
Open Access
Published: Dec 2020
24 citations
24 citations
1332 days before retraction
Combination therapy with anti‐T‐cell immunoglobulin and mucin‐domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma
K.P. Kim, Hye Won Lee, Jinsil Seong
Journal of Gastroenterology and Hepatology
Published: Nov 2020
11 citations
11 citations
1342 days before retraction
Study on Tim3 Regulation of Multiple Myeloma Cell Proliferation via NF-κB Signal Pathways
Zhaoyun Liu, Chenhuan Xiang, Mei Han et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Nov 2020
14 citations
14 citations
1344 days before retraction
Targeting TIM-3 in solid tumors: innovations in the preclinical and translational realm and therapeutic potential
Reem Saleh, Salman M. Toor, Eyad Elkord
Expert Opinion on Therapeutic Targets
Published: Oct 2020
19 citations
19 citations
1369 days before retraction
Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers
Maria Davern, Joanne Lysaght
Cancer Letters
Open Access
Published: Sep 2020
61 citations
61 citations
1407 days before retraction
Peer Review #2 of "Mining of prognosis-related genes in cervical squamous cell carcinoma immune microenvironment (v0.1)"
Jiong Ma, Pu Cheng, Xuejun Chen et al. (5 authors)
Unknown Journal
Open Access
Published: Aug 2020
1431 days before retraction
Peer Review #1 of "Mining of prognosis-related genes in cervical squamous cell carcinoma immune microenvironment (v0.1)"
Jiong Ma, Pu Cheng, Xuejun Chen et al. (5 authors)
Unknown Journal
Open Access
Published: Aug 2020
1431 days before retraction
Mining of prognosis-related genes in cervical squamous cell carcinoma immune microenvironment
Jiong Ma, Pu Cheng, Xuejun Chen et al. (5 authors)
PeerJ
Open Access
Published: Aug 2020
6 citations
6 citations
1431 days before retraction
Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation
Shuang Qin, Bing Dong, Ming Yi et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Aug 2020
45 citations
45 citations
1451 days before retraction
Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment
Paweł Łaniewski, Haiyan Cui, Denise J. Roe et al. (5 authors)
npj Precision Oncology
Open Access
Published: Aug 2020
30 citations
30 citations
1452 days before retraction
Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer
Jianlei Wu, Jian Zhao, Haibo Zhang et al. (6 authors)
Gynecologic Oncology
Published: Jul 2020
15 citations
15 citations
1467 days before retraction
Targeting novel inhibitory receptors in cancer immunotherapy
Quanquan Ding, Joë-Marc Chauvin, Hassane M. Zarour
Seminars in Immunology
Open Access
Published: Jun 2020
13 citations
13 citations
1515 days before retraction
Tim-3 finds its place in the cancer immunotherapy landscape
Nandini Acharya, Catherine Sabatos-Peyton, Ana C. Anderson
Journal for ImmunoTherapy of Cancer
Open Access
Published: Jun 2020
342 citations
342 citations
1515 days before retraction
Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis
Yaping Wang, Shujun Zhao, Xinlu Zhang et al. (11 authors)
Translational Cancer Research
Open Access
Published: Apr 2020
6 citations
6 citations
1576 days before retraction
Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia
Jacob Curley, Mark R. Conaway, Zachary Chinn et al. (6 authors)
Modern Pathology
Open Access
Published: Mar 2020
41 citations
41 citations
1602 days before retraction
<p>TIM-3 Participates in the Invasion and Metastasis of Nasopharyngeal Carcinoma via SMAD7/SMAD2/SNAIL1 Axis-Mediated Epithelial-Mesenchymal Transition</p>
Yangyang Xiao, Jilin Qing, Baoxuan Li et al. (8 authors)
OncoTargets and Therapy
Open Access
Published: Mar 2020
20 citations
20 citations
1607 days before retraction
Prognostic and clinicopathological value of high expression of <scp>TIM</scp>‐3 in different cancer types: A meta‐analysis
Wenbo Xu, Feng Qi, Ruidi Jiao et al. (8 authors)
Precision Medical Sciences
Open Access
Published: Mar 2020
3 citations
3 citations
1607 days before retraction
Soluble Tim3 detection by time‐resolved fluorescence immunoassay and its application in membranous nephropathy
Ming Chen, Liang Wang, Yigang Wang et al. (8 authors)
Journal of Clinical Laboratory Analysis
Open Access
Published: Feb 2020
20 citations
20 citations
1617 days before retraction
Transcriptomic Profiling of Tumor-Infiltrating CD4+TIM-3+ T Cells Reveals Their Suppressive, Exhausted, and Metastatic Characteristics in Colorectal Cancer Patients
Varun Sasidharan Nair, Salman M. Toor, Rowaida Z. Taha et al. (11 authors)
Vaccines
Open Access
Published: Feb 2020
26 citations
26 citations
1631 days before retraction
Study of T-cell immunoglobulin and mucin domain-3 expression profile in peripheral blood and bone marrow of human acute lymphoblastic leukemia patients
Mahmoud Aghaei, NargesZargar Balajam, Mahdi Shabani et al. (5 authors)
Journal of Research in Medical Sciences
Open Access
Published: Jan 2020
7 citations
7 citations
1667 days before retraction
T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer
Keyi Jia, Yayi He, Rafał Dziadziuszko et al. (11 authors)
Translational Lung Cancer Research
Open Access
Published: Dec 2019
43 citations
43 citations
1698 days before retraction
Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer
Li Zhang, Sijuan Tian, Meili Pei et al. (10 authors)
Oncology Reports
Open Access
Published: Oct 2019
36 citations
36 citations
1736 days before retraction
Significance of TIM3 expression in cancer: From biology to the clinic
Cinzia Solinas, Pushpamali De Silva, Dominique Bron et al. (5 authors)
Seminars in Oncology
Open Access
Published: Aug 2019
61 citations
61 citations
1820 days before retraction
The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical Cancer
Sophie Otter, Jayanta Chatterjee, Alexandra Stewart et al. (4 authors)
Clinical Oncology
Open Access
Published: Jul 2019
72 citations
72 citations
1833 days before retraction
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution
Veronica Mollica, Vincenzo Di Nunno, Lidia Gatto et al. (11 authors)
Clinical Drug Investigation
Published: Apr 2019
31 citations
31 citations
1942 days before retraction
TIM-3 in endometrial carcinomas: an immunotherapeutic target expressed by mismatch repair-deficient and intact cancers
Margaret E. Moore, Kari L. Ring, Anne M. Mills
Modern Pathology
Open Access
Published: Mar 2019
32 citations
32 citations
1945 days before retraction
Tim-3 expression in glioma cells is associated with drug resistance
Ji Zhang, Zheng Zhu, Yan Xia Li et al. (8 authors)
Journal of Cancer Research and Therapeutics
Open Access
Published: Jan 2019
11 citations
11 citations
2032 days before retraction
On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment
Grazia R. Tundo, Diego Sbardella, Pedro Miguel Lacal et al. (5 authors)
Chemotherapy
Open Access
Published: Jan 2019
37 citations
37 citations
2032 days before retraction
Immunoregulation effects of TIM-3 on tumors
Chunjie Sheng, Fuyan Han
Neoplasma
Open Access
Published: Dec 2018
14 citations
14 citations
2060 days before retraction
Tim-3 expression and its role in hepatocellular carcinoma
Feifei Liu, Yanning Liu, Zhi Chen
Journal of Hematology & Oncology
Open Access
Published: Oct 2018
113 citations
113 citations
2114 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #64882
Mar 29, 2016Quick Stats
Total Citations:
141
Years Since Retraction:
1.3 year
Open Access:
Yes
Last Checked:
Jul 24, 2025